The observed causal relationships between APOB inhibition and reduced lung cancer risk in ever-smokers and LUAD risk are particularly noteworthy, as neutral ceramidase plays a significant mediating role in these relationships. This evidence concerns the gene ASAH2 and lung carcinoma.